Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Drug Metabolism and Pharmacokinetics · Published 2026-07-01 · DOI 10.1016/j.dmpk.2026.101549

Free full text

Authors (9)

Koushi Higashi, Tomohiro Sasaki, Hikari Takahashi, Yosuke Kawai, Stefanie Hennig, Koichi Shimizu, Masami Nakai, Kaneyoshi Takahashi, Yu Nakamura

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Higashi, K., Sasaki, T., Takahashi, H., et al. (2026). Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2026.101549

Related articles

• Effect of substrates and inhibitors of breast cancer resistance protein on apixaban and rivaroxaban pharmacokinetics in Japanese patients · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Highly deep quantitative proteomics elucidate the mechanism of Alzheimers’ disease targeting reactive astrocyte · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Metabolism of pirocarpine in chimeric mice with humanized liver · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Transport characteristics of extracellular vesicles derived from human trophoblast stem cells in human blood-brain barrier endothelial cells · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8 · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma · Drug Metabolism and Pharmacokinetics · 2026 · Same journal
• Impact of unit notations on quantitative biodistribution analysis of adeno-associated virus vectors-based gene therapy products · Drug Metabolism and Pharmacokinetics · 2026 · Same journal
• Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Stability testing and metabolite profiling to support optimization of cyclic peptides for oral delivery · Drug Metabolism and Pharmacokinetics · 2025 · Same journal
• Effect of the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on expression of breast cancer resistance protein (BCRP/ABCG2) in human kidney epithelial cell line HK-2 · Drug Metabolism and Pharmacokinetics · 2025 · Same journal